Fig. 9
From: INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer
Kaplan–Meier survival curves of HER2+ and basal subtype breast cancer cells shows that high levels of INHBA is associated with poor outcome in these patient subgroups. In contrast, there is no difference in survival based on INHBA levels in luminal subtype breast cancer patients (see Additional file 1: Fig. S3B)